Clinical Trial Results TV
September 2, 2019: Dr. Satoshi Yasuda and Dr. Arzu Kalayci Discuss: AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with at
Dr. Satoshi Yasuda and Dr. Arzu Kalayci Discuss: AFIRE - Rivaroxaban monotherapy versus
dual therapy in patients with atrial fibrillation and stable coronary artery disease

TBA

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
11-17-2019 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted